As a result of demonstrating with the ACPi manual V100 centered on the pharmaceutical dispensing team of about 20 tertiary hospitals in the province, including the top hospitals in Korea, most hospitals, except for some hospitals that purchased the robot, most hospitals actively request a demo first, and from the beginning of July, the demo will be conducted with 5 additionally made demo units. In particular, most national and public hospitals in rural areas that are inferior to private hospitals are actively requesting demos.

Until now, most Advanced general hospitals have only had information about dispensing robots, From concept-level information on ACPi, ACPi is the world's first fully closed system, so they confirmed that it is possible to prepare a large amount of 5FU anticancer drug that a robot cannot, powder preparation without positive pressure, TPN preparation, PCA balloon charging, no negative pressure, extraction of the entire amount, etc. Relatively lower product price compared to expensive robots, no need for additional facilities, no management and maintenance costs (robot 6 million won per month), use in existing BSC facilities, and a combination with a single automatic that will be released soon. 95% or more dispensing range (24.8% for robots), 100% direct development of S/W, H/W, etc. by domestic companies, the innovative conditions such as rapid A/S, B/S (Before Service), and C/S are now It is the result of visually confirming the competitiveness of solving the difficult problems of anticancer drug preparation at once.

Some of the people in charge of dispensing that I learned from the Anyfusion ACPi demonstration were introduced (rumors) to the dispensing officials of other hospitals, and information about ACPi is being shared in the pharmaceutical department of high-level hospitals to some extent. It is expected to be introduced through more word-of-mouth and hospital pharmacists if the contents introduced in the demonstration are confirmed with a real demo starting in July.

Most of the hospitals demonstrated so far have reviewed the purchase of robots, and as a result of the review, the cost-effectiveness (efficiency) compared to the price (cost) has significantly fallen, and these are hospitals that have given up on the purchase of robots.

ACPi with high cost-effectiveness is becoming good news, and the publicity effect of building robots with medical institutions that purchased robots because there was no alternative, and the development of ACPi by domestic companies, which is showing high response in Japan, is being devalued. Many hospitals that are planning to purchase a robot after rejecting the Anyfusion ACPi reliability and lack of reference and evidence, reject the ACPi and the medical institutions that purchased the robot and proceed with the robot purchase when the results of the verified ACPi competitiveness compared to the ACPi actual robot are talked about. Hospitals are expected to face significant difficulties.

The medical staff of the hospital who have used Anyfusion H100 pump for more than 1 year, even though Meinntech did not request it, highly evaluated the A/S that was not compared to the unkindness of the existing foreign company, such as version up and regular calibration with an upgrade. We will always do our best to provide the best demo and actual results with the initial intention.

Thank you.